Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Cancer Treatment
100%
Stearoyl-CoA Desaturase 1 (SCD1)
100%
Immunogenicity
50%
Tumor
50%
Immune-competent
50%
Immune Checkpoint Inhibitors
33%
Toxicity Study
33%
New Drugs
33%
Adaptive Immune Response
33%
Immune Checkpoint Blockade
33%
Monounsaturated Fatty Acids
33%
Poorly Immunogenic Tumors
33%
De Novo Lipogenesis
33%
Mouse Model
33%
Endoplasmic Reticulum Stress (ER stress)
16%
Anti-PD-1 Antibody
16%
Metabolic Reprogramming
16%
Response Rate
16%
Combination Therapy
16%
Antitumor Activity
16%
Prognostic Biomarker
16%
Human Cancer
16%
Prognostic Marker
16%
T Cells
16%
Breast
16%
Oncogenesis
16%
Cancer Immunotherapy
16%
Patient Response
16%
Phase I Trial
16%
Tumor Cell Death
16%
Fatty Acid Synthesis
16%
Cancer Cell Lines
16%
HER2 Breast Cancer
16%
New Drug Application
16%
Rate-limiting Enzyme
16%
Activated T Cells
16%
Attenuation
16%
Immune-suppressive
16%
Antitumor Synergy
16%
Malignancy
16%
Mouse Tumor Model
16%
Cell Tumor
16%
Aggressive Tumor
16%
Long-term Survival
16%
Fatty Acid Metabolism
16%
Following Task
16%
Tumor Mouse Model
16%
FDA Approval
16%
Pre-investigation
16%
Biomarkers of Response
16%
Cell-based
16%
Novel Leads
16%
Calreticulin
16%
Mouse Breast Cancer
16%
Deprivation
16%
Compound Stability
16%
Well Tolerated
16%
Immune-mediated
16%
Anticancer Target
16%
Antibody Therapy
16%
Cancer Cells
16%
Apoptotic Cell Death
16%
Saturated Acids
16%
Endoplasmic Reticulum Stress Pathway
16%
Tumor Immunogenicity
16%
Early Phase Clinical Trials
16%
Complete Regression
16%
Anti-PD-1 Inhibitor
16%
Regulation Strategy
16%
T Cell Tumor Infiltration
16%
Immunology and Microbiology
Mouse Model
100%
Immunogenicity
75%
Immune Checkpoint Inhibitor
50%
Fatty Acid
50%
Immune Checkpoint Blockade
50%
Lipogenesis
50%
Endoplasmic Reticulum Stress
50%
T Cell
50%
Cancer Cell Line
25%
Long Term Survival
25%
Fatty Acid Metabolism
25%
Tumor Immunogenicity
25%
Fatty Acid Synthesis
25%
Tumor Cell
25%
Cancer Cell
25%
Cancer Immunotherapy
25%
Calreticulin
25%
Adaptive Immune System
25%
Cell Killing
25%
Arm
25%
Antineoplastic Activity
25%
Programmed Cell Death
25%
Rat
25%
Dog
25%
Biochemistry, Genetics and Molecular Biology
Stearoyl-CoA Desaturase-1
100%
Mouse Model
66%
Immunogenicity
50%
Immune Checkpoint Inhibitor
33%
Immune Checkpoints
33%
Lipogenesis
33%
Monounsaturated Fat
33%
T Cell
33%
Cancer Cell
33%
Endoplasmic Reticulum Stress
33%
Clinical Trial
33%
Antineoplastic Activity
16%
Cell Killing
16%
Long Term Survival
16%
Fatty Acid Metabolism
16%
Calreticulin
16%
Cancer Immunotherapy
16%
Rat
16%
Tumor Immunogenicity
16%
Fatty Acid Synthesis
16%
Adaptive Immunity
16%
Carcinogenesis
16%
Dog
16%
Cancer Model
16%
Enzyme
16%
Programmed Cell Death
16%
Anticancer
16%
Reprogramming
16%